These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8635072)

  • 1. Primary hypothyroidism as a consequence of 131-I-metaiodobenzylguanidine treatment for children with neuroblastoma.
    Picco P; Garaventa A; Claudiani F; Gattorno M; De Bernardi B; Borrone C
    Cancer; 1995 Nov; 76(9):1662-4. PubMed ID: 8635072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hypothyroidism and 131I-MIBG therapy in neuroblastoma.
    Picco P; Garaventa A; Claudiani F; Garibaldi L; Borrone C
    Lancet; 1993 Jul; 342(8862):57. PubMed ID: 8100332
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
    Quach A; Ji L; Mishra V; Sznewajs A; Veatch J; Huberty J; Franc B; Sposto R; Groshen S; Wei D; Fitzgerald P; Maris JM; Yanik G; Hawkins RA; Villablanca JG; Matthay KK
    Pediatr Blood Cancer; 2011 Feb; 56(2):191-201. PubMed ID: 20830775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroid dysfunction due to 131I-metaiodobenzylguanidine in patients with neuroblastoma].
    Garrido Magaña E; Silva Estrada JA; Nishimura Meguro E; Rivera Hernández AJ; Zurita Cruz JN
    Rev Chil Pediatr; 2020 Jun; 91(3):379-384. PubMed ID: 32730518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with neuroblastoma treated with 125-I MIBG.
    Sisson JC; Shapiro B; Hutchinson RJ; Shulkin BL; Zempel S
    Am J Clin Oncol; 1996 Apr; 19(2):144-8. PubMed ID: 8610638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.
    Clement SC; van Rijn RR; van Eck-Smit BL; van Trotsenburg AS; Caron HN; Tytgat GA; van Santen HM
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):706-15. PubMed ID: 25512056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.
    van Santen HM; Tytgat GA; van de Wetering MD; van Eck-Smit BL; Hopman SM; van der Steeg AF; Nieveen van Dijkum EJ; van Trotsenburg AS
    Thyroid; 2012 Jun; 22(6):643-6. PubMed ID: 22524499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.
    Clement SC; van Eck-Smit BL; van Trotsenburg AS; Kremer LC; Tytgat GA; van Santen HM
    Pediatr Blood Cancer; 2013 Nov; 60(11):1833-8. PubMed ID: 23832530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
    Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
    Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.
    van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
    Cancer; 2002 Apr; 94(7):2081-9. PubMed ID: 11932913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
    Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
    J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
    Hutchinson RJ; Sisson JC; Shapiro B; Miser JS; Normole D; Shulkin BL; Francis IR; Zasadny K; Carey JE; Johnson JW
    Am J Clin Oncol; 1992 Jun; 15(3):226-32. PubMed ID: 1590275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
    De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
    Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
    Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
    Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
    van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
    Cancer; 2003 Jul; 98(2):389-96. PubMed ID: 12872361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
    Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.
    Clement SC; Kraal KC; van Eck-Smit BL; van den Bos C; Kremer LC; Tytgat GA; van Santen HM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E112-6. PubMed ID: 24187404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.
    Sisson JC; Shapiro B; Hutchinson RJ; Carey JE; Zasadny KR; Zempel SA; Normolle DP
    Eur J Nucl Med; 1994 Jan; 21(1):46-52. PubMed ID: 8088285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
    Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
    J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.